[1]
Bentzen, J. et al. 2015. Locally advanced head and neck cancer treated with accelerated radiotherapy, the hypoxic modifier nimorazole and weekly cisplatin. Results from the DAHANCA 18 phase II study. Acta Oncologica. 54, 7 (Aug. 2015), 1001–1007. DOI:https://doi.org/10.3109/0284186X.2014.992547.